Abhinav Bassi's Publications

Innovative mobile-health led participatory approach to comprehensive screening and treatment of diabetes (IMPACT diabetes): rationale, design, and baseline characteristics
Journal articles
2023
International Journal of Diabetes in Developing Countries
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
Journal articles
2022
Trials
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India
Journal articles
2022
BMJ Open
Long-term outcomes of dexamethasone 12mg versus 6mg in patients with COVID-19 and severe hypoxaemia
Journal articles
2022
Intensive Care Medicine
Challenges in operationalising clinical trials in India during the COVID-19 pandemic
Journal articles
2022
The Lancet Global Health
Angiotensin receptor blockers for the treatment of covid-19: Pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
Journal articles
2022
BMJ
Dexamethasone 12mg versus 6mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial
Journal articles
2022
Intensive Care Medicine
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
Journal articles
2021
Trials
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive without Life Support in Adults with COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial
Journal articles
2021
JAMA - Journal of the American Medical Association
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan
Journal articles
2021
Acta Anaesthesiologica Scandinavica
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis
Journal articles
2021
Acta Anaesthesiologica Scandinavica
Relationship between measured and prescribed dialysate sodium in haemodialysis: A systematic review and meta-Analysis
Journal articles
2021
Nephrology Dialysis Transplantation
Statistical Analysis Plan for the HydrOxychloroquine Prophylaxis Evaluation (HOPE) trial
Journal articles
2021
Innovative mobile-health led Participatory Approach to Comprehensive Screening and Treatment of Diabetes (IMPACT Diabetes): Rationale, Design and Baseline Characteristics (Preprint)
Journal articles
2021
Hydroxychloroquine Plus Standard Personal Protective Equipment Versus Standard Personal Protective Equipment Alone for the Prevention of Laboratory Confirmed Covid-19 Infections Among Healthcare Workers: A Multi-Centre Parallel Group Randomized Controlled Trial from India
Preprints
2021
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
Preprints
2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial
Journal articles
2021
POS-527 CONTINUUM OF CARE AMONG PARTICIPANTS OF DIALYSIS OUTCOMES REGISTRY IN INDIA DURING THE COVID-19 PANDEMIC LOCKDOWN
Journal articles
2021
Kidney International Reports
Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: The HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial
Journal articles
2020
Trials
An overview of mobile applications (apps) to support the coronavirus disease 2019 response in India
Journal articles
2020
Indian Journal of Medical Research
SAT-299 Change in Health-Related Quality of Life over 18 Months among Individuals on Maintenance Haemodialysis in India
Journal articles
2020
Kidney International Reports
SUN-180 SOCIO-DEMOGRAPHIC CHARACTERISTICS AND OUTCOMES AT 18 MONTHS OF A COHORT OF ESKD PATIENTS STARTING HEMODIALYSIS IN INDIA
Journal articles
2020
Kidney International Reports
Methodological challenges to collecting clinical and economic outcome data: Lessons from the pilot dialysis outcomes India study
Journal articles
2019
Nephrology
SAT-039 Socio-Demographic Characteristics, Out of Pocket Expenditure, Quality of Life and Six Months Treatment Outcomes of Haemodialysis Patients in India
Journal articles
2019
Kidney International Reports
Current status and future directions of mhealth interventions for health system strengthening in India: Systematic review
Journal articles
2018
JMIR mHealth and uHealth
Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India
Journal articles
2018
Kidney International